Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO Cohort Study analysis.
Brooj AbroMatthew John MaurerThomas M HabermannW Richard BurackJennifer R ChapmanJonathon B CohenJonathan W FriedbergGiorgio Ga InghiramiBrad S KahlMelissa C LarsonBrian L LinkIzidore S LossosPeter MartinTimothy McDonnellLoretta J NastoupilShaun RiskaSergei I SyrbuFrancisco VegaKiran VijChristopher R FlowersJames R CerhanDavid L JayeAndrew L FeldmanPublished in: Blood (2024)
Recent introduction of two different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that differences between the classifications will impact <1% of non-Hodgkin lymphomas.